We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warning Letters to Foreign Facilities Soar in 2017
FDA Warning Letters to Foreign Facilities Soar in 2017
FDA warning letters to foreign drug and API manufacturing facilities have increased more than tenfold so far this year compared to the same period in 2016.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor